Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score

被引:53
作者
Chen, G
Zheng, SX
Luo, XM
Shen, JH
Zhu, WL
Liu, H
Gui, CS
Zhang, J
Zheng, MY
Puah, CM
Chen, KX
Jiang, HL
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Shanghai 201203, Peoples R China
[4] Singapore Polytech, Technol Ctr Life Sci, Singapore 139651, Singapore
[5] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
来源
JOURNAL OF COMBINATORIAL CHEMISTRY | 2005年 / 7卷 / 03期
关键词
D O I
10.1021/cc049866h
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The advent of focused library and virtual screening has reduced the disadvantage of combinatorial chemistry and changed it to a realizable and cost-effective tool in drug discovery. Usually, genetic algorithms (GAs) are used to quickly finding high-scoring molecules by sampling a small subset of the total combinatorial space. Therefore, scoring functions play essential roles in focused library design. Reported here is our initial attempt to establish a new approach for generating a target-focused library using, the combination of the scores of structural diversity and binding affinity with our newly improved druglikeness scoring functions. Meanwhile, a software package, named LD1.0, was developed on the basis of the new approach. One test on a cyclooxygenase (COX)2-focused library successfully reproduced the structures that have been experimentally studied as COX2-selective inhibitors. Another test is on a peroxisome proliferator-activated receptors gamma-focused library design, which not only reproduces the key fragments in the approved (thiazolidinedione) TZD drugs, but also generates some new structures that are more active than the approved drugs or published ligands. Both of the two tests took similar to 15% of the running time of the ordinary molecular docking method. Thus, our new approach is an effective, reliable, and practical way for building up a properly sized focused library with a high hit rate, novel structure, and good ADME/T profile.
引用
收藏
页码:398 / 406
页数:9
相关论文
共 69 条
[1]  
*ACC INC, 2002, INS 2000 1
[2]   Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? [J].
Ajay ;
Walters, WP ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3314-3324
[3]  
ALEXANDER G, 2000, J CHEMINF COMPUT SCI, V40, P414
[4]   New perspectives in lead generation .2. Evaluating molecular diversity [J].
Ashton, MJ ;
Jaye, MC ;
Mason, JS .
DRUG DISCOVERY TODAY, 1996, 1 (02) :71-78
[5]   Use of structure Activity data to compare structure-based clustering methods and descriptors for use in compound selection [J].
Brown, RD ;
Martin, YC .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (03) :572-584
[6]  
Brown RD, 1997, PERSPECT DRUG DISCOV, V7-8, P31
[7]   Inhibitors of cyclooxygenase-2: November 1999-April 2000 [J].
Carter, JS .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (07) :1011-1020
[8]  
Clark DE, 2002, ADV DRUG DELIVER REV, V54, P253
[9]   Computational methods for the prediction of 'drug-likeness' [J].
Clark, DE ;
Pickett, SD .
DRUG DISCOVERY TODAY, 2000, 5 (02) :49-58
[10]   RENAL SYNDROMES ASSOCIATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
CLIVE, DM ;
STOFF, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (09) :563-572